Elevated levels of circITGB6 in cisplatin-resistant ovarian cancer cells form a complex with the RNA-binding protein IGF2BP2 and fibroblast growth factor 9 (FGF9) mRNA. Here, RBMS3 is linked to ovarian carcinoma.